-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Neumora Therapeutics, Inc. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Dec 2022 to 31 Mar 2025.
- Neumora Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $59,448,000, a 38% decline year-over-year.
- Neumora Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $182,936,000, a 12% decline from 2023.
- Neumora Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $163,278,000, a 42% decline from 2022.